← Leaderboards
Raymond Ranken
Isis Pharmaceuticals, Inc.
$838,950
Attributed
$838,950
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $406.8K · FY2008–09$500K$375K$250K$125K$0
'08
'09
Funding mix
By agency
NIH$838,950 · 2
By mechanism
R44$744,910 · 1
R43$94,040 · 1
Top collaborators
No co-investigators on record.
Most similar at Isis Pharmaceuticals, Inc.
Same institution · by research overlap
- David J Ecker$0
- Lawrence B Blyn$5,462,112
Others in their field
Top investigators on “Hepatitis C Virus”
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Sharon A Nachman · Johns Hopkins University$91,575,784
- Peter B. Gilbert · Fred Hutchinson Cancer Center$77,122,577
- Robert Turner Schooley · University Of Colorado Denver$45,719,253
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$44,694,148
- Charles M. Rice · Rockefeller University$42,549,577
Research focus
Hepatitis C VirusMalariaBlood BanksHerpesvirus 1, HumanInfectionBloodHazardHepatitis B VirusBlood-Borne PathogensBirdsHiv-2Cessation Of LifeChagas DiseaseChronicHiv-1FlavivirusHepatitis A VirusCommunicable DiseasesDengue VirusDetectionDonor SelectionBlood ScreeningBlindedMember